Lymphoma patients and their families and carers are offered several opportunities to give and receive help. The first of these is the Cell Mates programme, through which patients and survivors are put in touch with others who may be in a similar situation. The one-to-one matching is performed by LRFA and is based on a variety of factors, including disease and treatment type, age, gender, place of residence and other interests, though the degree of matching can be requested by the Mate. There are also support and networking groups which operate on a US state-wide level, offering meeting places for patients and their families. For those without access to these meetings, LRFA plans to host internet ‘chats’ to simulate the interactive support gained from face-to-face meetings. In addition, the message board offers an open forum for patients to post queries and to share experiences. Judging by the recent posting dates, and the frequency with which people have logged on to each posting, this appears to be a welcome resource. From a physician’s perspective, a new linked site (lymphomafocus.org) provides a host of presentations, links to ‘webcasts’ and audio broadcasts by experts in the field of many aspects of lymphoma research and optimal treatment. Health professionals are also invited to join the online community of researchers, and can receive prior notification of web events by email. In terms of ease of use, I rate lymphoma.org six out of ten. Though the screen is split into two, with the left side always displaying the site index, though only the main section headings and not the sub-headings which can be accessed using this index. The most frustrating element of the website is the number of links that fail. For example, on trying to get further information on each of the patient educational programmes, an error was returned (requested URL not found) in the majority of cases. Despite these annoyances, lymphoma.org offers a comprehensive source of information, and is likely to be of benefit for patients requiring an understanding of lymphomas and physicians who require up to date knowledge on treatment and recent research findings.